Technical Analysis for AWH - Aspira Women's Health Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.73 | 2.46% | 0.02 |
AWH closed up 2.46 percent on Wednesday, November 20, 2024, on 53 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
Doji - Bullish? | Reversal | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
New 52 Week Low | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
New 52 Week Closing Low | Bearish | 2.46% | |
Stochastic Buy Signal | Bullish | 2.46% | |
Lower Bollinger Band Walk | Weakness | 2.46% |
Alert | Time |
---|---|
Up 3% | about 21 hours ago |
Up 2% | about 21 hours ago |
Up 1% | about 21 hours ago |
60 Minute Opening Range Breakdown | 2 days ago |
Down 5% | 2 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/11/2024
Aspira Women’s Health Inc. (formerly known as Vermillion, Inc. Nasdaq: VRML) is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1®plus combines our FDA-cleared products OVA1® and OVERA® to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiXSM testing offers both targeted and a more comprehensive genetic testing options with a gynecologic focus. Our focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine Oncology Healthcare Providers FDA Ovarian Cancer Genetic Testing Patient Management Analytical Solutions Gynaecological Cancer Gynaecology
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine Oncology Healthcare Providers FDA Ovarian Cancer Genetic Testing Patient Management Analytical Solutions Gynaecological Cancer Gynaecology
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.65 |
52 Week Low | 0.6679 |
Average Volume | 96,189 |
200-Day Moving Average | 2.06 |
50-Day Moving Average | 0.84 |
20-Day Moving Average | 0.85 |
10-Day Moving Average | 0.79 |
Average True Range | 0.09 |
RSI (14) | 33.33 |
ADX | 20.9 |
+DI | 13.19 |
-DI | 19.79 |
Chandelier Exit (Long, 3 ATRs) | 1.10 |
Chandelier Exit (Short, 3 ATRs) | 0.94 |
Upper Bollinger Bands | 1.01 |
Lower Bollinger Band | 0.70 |
Percent B (%b) | 0.11 |
BandWidth | 36.60 |
MACD Line | -0.04 |
MACD Signal Line | -0.02 |
MACD Histogram | -0.0175 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.85 | ||||
Resistance 3 (R3) | 0.84 | 0.80 | 0.83 | ||
Resistance 2 (R2) | 0.80 | 0.76 | 0.80 | 0.82 | |
Resistance 1 (R1) | 0.76 | 0.75 | 0.77 | 0.77 | 0.82 |
Pivot Point | 0.72 | 0.72 | 0.72 | 0.72 | 0.72 |
Support 1 (S1) | 0.68 | 0.68 | 0.69 | 0.69 | 0.64 |
Support 2 (S2) | 0.64 | 0.67 | 0.64 | 0.64 | |
Support 3 (S3) | 0.60 | 0.64 | 0.63 | ||
Support 4 (S4) | 0.61 |